149 related articles for article (PubMed ID: 7795136)
21. National blood program in Korea.
Han KS; Kim SI
Artif Cells Blood Substit Immobil Biotechnol; 1999 Mar; 27(2):179-83. PubMed ID: 10092939
[TBL] [Abstract][Full Text] [Related]
22. When less is more: cost-containment in transfusion medicine.
Petrides M
Transfus Sci; 1997 Dec; 18(4):603-12. PubMed ID: 10178686
[TBL] [Abstract][Full Text] [Related]
23. Re-examining blood use to improve quality care.
Simmons JC
Qual Lett Healthc Lead; 2001 Sep; 13(9):2-12, 1. PubMed ID: 11570060
[TBL] [Abstract][Full Text] [Related]
24. The annual cost of blood transfusions in the UK.
Varney SJ; Guest JF
Transfus Med; 2003 Aug; 13(4):205-18. PubMed ID: 12880391
[TBL] [Abstract][Full Text] [Related]
25. [Hemovigilance: a joint responsibility of hospitals and blood banks].
van Aken WG
Ned Tijdschr Geneeskd; 2003 Aug; 147(31):1490-2. PubMed ID: 12924077
[TBL] [Abstract][Full Text] [Related]
26. Is there a limit to the normality of blood products?
Hughes WG
Hematol J; 2001; 2(3):212. PubMed ID: 11920249
[No Abstract] [Full Text] [Related]
27. [Peru's experience with a national blood banking program].
Ribera Salcedo JF; Roca Valencia O
Rev Panam Salud Publica; 2003; 13(2-3):165-71. PubMed ID: 12751465
[TBL] [Abstract][Full Text] [Related]
28. ["Gift or good?"].
Van Aken WG
Transfus Clin Biol; 2006 Sep; 13(3):196-9. PubMed ID: 16931090
[TBL] [Abstract][Full Text] [Related]
29. [Blood donation: a constantly evolving concept].
Gimeno JJ; Buñuel C
Sangre (Barc); 1996 Dec; 41(6):413-6. PubMed ID: 9148418
[No Abstract] [Full Text] [Related]
30. The development of plasma derivatives in Switzerland.
Kistler P
Vox Sang; 1972; 23(1):26-31. PubMed ID: 5081011
[No Abstract] [Full Text] [Related]
31. Current and emerging infectious risks of blood transfusions.
Busch MP; Kleinman SH; Nemo GJ
JAMA; 2003 Feb; 289(8):959-62. PubMed ID: 12597733
[No Abstract] [Full Text] [Related]
32. Self-sufficiency for plasma and plasma proteins in Norway.
Solheim BG; Eggen BM; Heier HE
Beitr Infusionsther Transfusionsmed; 1996; 33():98-102. PubMed ID: 8865939
[TBL] [Abstract][Full Text] [Related]
33. Organizational changes in Estonia.
Everaus H
Vox Sang; 1998; 74 Suppl 2():531-3. PubMed ID: 9704495
[TBL] [Abstract][Full Text] [Related]
34. NBA/NBS perspective on nvCJD.
Wallington T
Transfus Sci; 1998 Dec; 19(4):329-30. PubMed ID: 10351146
[No Abstract] [Full Text] [Related]
35. 50 million Pounds for America's safe blood.
Cooper R
Br J Perioper Nurs; 2003 Mar; 13(3):92. PubMed ID: 12677882
[No Abstract] [Full Text] [Related]
36. Management of scarce resources in blood services in developing countries.
Martínez MC
Vox Sang; 2002 Aug; 83 Suppl 1():137-40. PubMed ID: 12617123
[No Abstract] [Full Text] [Related]
37. Self-sufficiency and blood transmitted diseases.
Glomstein A
Blood Coagul Fibrinolysis; 1995 Jul; 6 Suppl 2():S23-6. PubMed ID: 7495963
[TBL] [Abstract][Full Text] [Related]
38. Blood bank regulations in India.
Choudhury N; Desai P
Clin Lab Med; 2012 Jun; 32(2):293-9. PubMed ID: 22727006
[TBL] [Abstract][Full Text] [Related]
39. HIV and the blood supply: an analysis of crisis decision making. Executive summary. The Institute of Medicine, National Academy of Sciences Committee to Study HIV Transmission Through Blood and Blood Products.
Leveton LB; Sox HC; Stoto MA
Transfusion; 1996 Oct; 36(10):919-27. PubMed ID: 8863781
[No Abstract] [Full Text] [Related]
40. [Blood transfusion safety in a limited resources setting: the elaboration of a rational National Blood Policy in Togo].
Sodahlon YK; Segbena AY; Prince-David M; Gbo KA; Fargier MP; North ML; Malvy DJ
Sante; 2004; 14(2):115-20. PubMed ID: 15454371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
